Explore more publications!

Latest News

Labels On
FILTER THE FEED
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate
FILTER THE FEED
Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
Bizarre rules faced by Aussie mum Debbie Voulgaris in Taiwan jail as she lives in fear of making the tiniest mistake: Punishment means she'll NEVER forget to wear her slippers again

Bizarre rules faced by Aussie mum Debbie Voulgaris in Taiwan jail as she lives in fear of making the tiniest mistake: Punishment means she'll NEVER forget to wear her slippers again

Right-wing Daily Mail
Owner: Jonathan Harmsworth
Taiwan's ScinoPharm secures US FDA approval of Glatiramer Acetate Injection for MS treatment

Taiwan's ScinoPharm secures US FDA approval of Glatiramer Acetate Injection for MS treatment

Taiwan claims Chinese cyberattacks increased to 2.6 million a day, says report

Taiwan claims Chinese cyberattacks increased to 2.6 million a day, says report

Readers sound off on Medical Aid in Dying, invading Venezuela and ‘Peanuts’ specials

Readers sound off on Medical Aid in Dying, invading Venezuela and ‘Peanuts’ specials

asia Chinese cyberattacks on Taiwan infrastructure averaged 2.6 million a day in 2025, report says

asia Chinese cyberattacks on Taiwan infrastructure averaged 2.6 million a day in 2025, report says

Chinese cyber attacks on Taiwan infrastructure averaged 2.6 million a day in 2025: Report

Chinese cyber attacks on Taiwan infrastructure averaged 2.6 million a day in 2025: Report

Chinese cyberattacks on Taiwan infrastructure averaged 2.6 million a day in 2025, report says

Chinese cyberattacks on Taiwan infrastructure averaged 2.6 million a day in 2025, report says

Taiwan's ScinoPharm secures US FDA approval of Glatiramer Acetate Injection for MS treatment

Taiwan's ScinoPharm secures US FDA approval of Glatiramer Acetate Injection for MS treatment

Taiwan claims Chinese cyberattacks increased to 2.6 million a day, says report

Taiwan claims Chinese cyberattacks increased to 2.6 million a day, says report

Readers sound off on Medical Aid in Dying, invading Venezuela and ‘Peanuts’ specials

Readers sound off on Medical Aid in Dying, invading Venezuela and ‘Peanuts’ specials

asia Chinese cyberattacks on Taiwan infrastructure averaged 2.6 million a day in 2025, report says

asia Chinese cyberattacks on Taiwan infrastructure averaged 2.6 million a day in 2025, report says

Chinese cyber attacks on Taiwan infrastructure averaged 2.6 million a day in 2025: Report

Chinese cyber attacks on Taiwan infrastructure averaged 2.6 million a day in 2025: Report

Chinese cyberattacks on Taiwan infrastructure averaged 2.6 million a day in 2025, report says

Chinese cyberattacks on Taiwan infrastructure averaged 2.6 million a day in 2025, report says

Bizarre rules faced by Aussie mum Debbie Voulgaris in Taiwan jail as she lives in fear of making the tiniest mistake: Punishment means she'll NEVER forget to wear her slippers again

Bizarre rules faced by Aussie mum Debbie Voulgaris in Taiwan jail as she lives in fear of making the tiniest mistake: Punishment means she'll NEVER forget to wear her slippers again

Show More

Video Stories

YouTube video thumbnail:  Taiwan Entrepreneur Marketing Banana Fiber to the Global Apparel Industry
Play
Taiwan Entrepreneur Marketing Banana Fiber to the Global Apparel Industry
YouTube video thumbnail: Taiwan Band Brings History and Tradition to Life Through Music
Play
Taiwan Band Brings History and Tradition to Life Through Music
YouTube video thumbnail: Why is the World Running Short on Semiconductors?
Play
Why is the World Running Short on Semiconductors?
YouTube video thumbnail: BBC Travel Show - Taiwan special
Play
BBC Travel Show - Taiwan special

Video Title

Press Releases

Show More
Your brand’s story is being written — with or without you.
We’re the leading press release service for mid-sized businesses & organizations built for the AI era.
Learn more

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions